AI model developed by SOPHiA GENETICS and UroCCR predicts post-operative outcomes in kidney cancer study

SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, and the French Kidney Cancer Research Network collaborated on a study using a multimodal algorithm to help predict post-operative outcomes for those facing renal cell carcinoma, with the results recently published in npj Precision Oncology.

TREAT California Withdraws 2024 Ballot Initiative Efforts, Redirects Focus to TREAT Humanity | Psychedelic Spotlight

Sherman Oaks, Calif., November 2, 2023 — TREAT California, a citizen-driven ballot initiative to fund research and access for psychedelic medicines to treat mental health,

November 3, 2023

New Initiative Examines Misuse of Race in Medical Research

What You Should Know: Doris Duke Foundation (DDF) announce the launch of Racial Equity in Clinical Equations, a new initiative to examine the misuse of

June 28, 2023

EMA recommends expanding approval of Ofev to children and adolescents – Pharmaceutical Technology

Ofev generated global sales of $3.8bn for the German drugmaker in 2023, up 12.8% from the year before. Image credit: Shutterstock / Michael Vi. Boehringer

December 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.